Similarly, statistically non-significant trends were observed when the group of patients with clinically relevant ACR and those who did not present clinically relevant ACR were compared based on NT-proBNP (1499 pg/mL (798–2841) vs. 2070 pg/mL (757–7825), p = 0.23) and troponin levels (68.76 ng/L (42.7–186) vs. 87.93 ng/L (56.1–139), p = 0.31) in the first months after HT. This evidence concerns the gene NPPB and hematocrit.